Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Tuesday, February 13, 2018
Charles River Laboratories announced two new executive management appointments.
read more
Thursday, August 24, 2023
Charles River Laboratories International, Inc. announced a High Quality (HQ) plasmid manufacturing collaboration with Fondazione Telethon.
read more
Charles River Laboratories International Inc. announced a long-term solar energy contract to address the entirety of the Company’s North American electric power requirements with clean, renewable energy by 2023. Charles River and Duke Energy ...
read more
Thursday, October 14, 2021
Charles River Laboratories International announced that it has divested its Research Models and Services operations in Japan (RMS Japan) and its gene therapy CDMO site in Sweden (CDMO Sweden) in two separate transactions.
read more
Wednesday, April 16, 2014
Charles River Laboratories International, Inc. (NYSE: CRL) announced today that it has completed the previously announced acquisition of the CRO services division of Galapagos NV (Euronext: GLPG), which includes both Argenta and BioFocus. The ...
read more
Charles River Laboratories has completed the previously announced acquisition of MPI Research for approximately $800 million in cash, subject to certain customary adjustments.
read more
Charles River Laboratories announced that it has completed the acquisition of Vigene Biosciences, Inc. for $292.5 million. In addition to the initial purchase price, the transaction includes additional payments of up to $57.5 million, contingent on ...
read more
Thursday, October 18, 2012
Charles River Laboratories International, Inc. (NYSE: CRL) today announced that it has been selected by AstraZeneca (NYSE: AZN) as its preferred strategic partner for outsourced regulated safety assessment and development DMPK (drug metabolism and ...
read more
Charles River Laboratories has invested in Resero Analytics™, a software company focused on providing solutions to the biopharmaceutical industry to harness its data.
read more
Thursday, November 11, 2021
Charles River Laboratories International, Inc. announced that Birgit Girshick has been promoted to the position of Chief Operating Officer, effective immediately.
read more
Friday, February 15, 2019
Charles River Laboratories has signed a binding offer to acquire Citoxlab for €448 million in cash subject to customary closing adjustments.
read more
Charles River Laboratories has signed a definitive agreement to acquire Vigene Biosciences.
read more
Charles River Laboratories announced the appointment of Dr. Martin Mackay, Executive Vice President, Alexion Pharmaceuticals to its Board of Directors.
read more
Monday, December 23, 2019
Charles River Laboratories announced a definitive agreement to acquire HemaCare for approximately $380 million in cash.
read more
Wednesday, January 30, 2019
Charles River Laboratories and Toxys have entered into an agreement to offer access to ToxTracker in North America.
read more